Electrically induced ventricular arrhythmias in acute myocardial infarction treated with thrombolytic agents. 1988

J M McComb, and H K Gold, and R C Leinbach, and J B Newell, and J N Ruskin, and H Garan
Cardiac Unit, Massachusetts General Hospital, Harvard Medical School, Boston 02114.

Ninety-two patients underwent programmed ventricular stimulation 12 +/- 3 days after acute myocardial infarction (AMI) treated with thrombolytic agents (streptokinase, recombinant tissue plasminogen activator, or both). Cardiac catheterization was performed in all patients on admission to hospital and was repeated in 97% of them 13 +/- 5 days later. Sustained ventricular arrhythmias--either tachycardia (VT) or fibrillation--were induced in 20 (22%) patients, with nonsustained VT induced in another 12 (13%). Multivariate analysis was used to identify predictors of induction of sustained VT, with short right ventricular effective refractory period (p = 0.0061), site of AMI (inferior or posterior, p = 0.008), infarct-related artery (right or circumflex coronary artery, p = 0.018), multivessel coronary artery disease (p = 0.043) and male sex (p = 0.028) being significant predictors of sustained VT. Neither successful reperfusion, time to reperfusion, nor residual stenosis in the infarct-related artery was significant. All patients in whom VT was induced were treated with electrophysiologically guided antiarrhythmic therapy. Cardiac mortality after hospital discharge was 1% over 30 +/- 16 months.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D010959 Tissue Plasminogen Activator A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to FIBRINOLYSIN. It has fibrin-binding activity and is immunologically different from UROKINASE-TYPE PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases. Alteplase,Plasminogen Activator, Tissue-Type,T-Plasminogen Activator,Tissue-Type Plasminogen Activator,Actilyse,Activase,Lysatec rt-PA,TTPA,Tisokinase,Tissue Activator D-44,Lysatec rt PA,Lysatec rtPA,Plasminogen Activator, Tissue,Plasminogen Activator, Tissue Type,T Plasminogen Activator,Tissue Activator D 44,Tissue Type Plasminogen Activator
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002304 Cardiac Pacing, Artificial Regulation of the rate of contraction of the heart muscles by an artificial pacemaker. Pacing, Cardiac, Artificial,Artificial Cardiac Pacing,Artificial Cardiac Pacings,Cardiac Pacings, Artificial,Pacing, Artificial Cardiac,Pacings, Artificial Cardiac
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D004594 Electrophysiology The study of the generation and behavior of electrical charges in living organisms particularly the nervous system and the effects of electricity on living organisms.
D005260 Female Females

Related Publications

J M McComb, and H K Gold, and R C Leinbach, and J B Newell, and J N Ruskin, and H Garan
March 1989, The New England journal of medicine,
J M McComb, and H K Gold, and R C Leinbach, and J B Newell, and J N Ruskin, and H Garan
January 1988, Medicina,
J M McComb, and H K Gold, and R C Leinbach, and J B Newell, and J N Ruskin, and H Garan
January 1977, Postgraduate medical journal,
J M McComb, and H K Gold, and R C Leinbach, and J B Newell, and J N Ruskin, and H Garan
December 1993, Circulation,
J M McComb, and H K Gold, and R C Leinbach, and J B Newell, and J N Ruskin, and H Garan
May 1985, Journal of the American College of Cardiology,
J M McComb, and H K Gold, and R C Leinbach, and J B Newell, and J N Ruskin, and H Garan
April 1971, Southwestern medicine,
J M McComb, and H K Gold, and R C Leinbach, and J B Newell, and J N Ruskin, and H Garan
March 1988, Journal of the American College of Cardiology,
J M McComb, and H K Gold, and R C Leinbach, and J B Newell, and J N Ruskin, and H Garan
June 1991, Canadian journal of physiology and pharmacology,
J M McComb, and H K Gold, and R C Leinbach, and J B Newell, and J N Ruskin, and H Garan
January 1993, Zeitschrift fur Kardiologie,
J M McComb, and H K Gold, and R C Leinbach, and J B Newell, and J N Ruskin, and H Garan
April 1976, Indian heart journal,
Copied contents to your clipboard!